Clinical trial
Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB…
NCT00004201 · Herbert Irving Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00004201 |
|---|---|
| Title | Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer |
| Official title | A Randomized Phase II Trial of Cisplatin or Carboplatin With Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Herbert Irving Comprehensive Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, cisplatin, gemcitabine hydrochloride |
| Completion | Aug 1, 2004 |
| First posted | Aug 30, 2004 |
| Last update posted | Feb 4, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: